The somatotropic axis in short children born small for gestational age: Relation to insulin resistance

Pediatric Research

Volumn 51, Issue 1, 2002, Pages 76-80

  Woods, K A ^a   Van Helvoirt, M ^a   Ong, K K L ^a   Mohn, A ^a   Levy, J ^a   De Zegher, F ^a   Dunger, D B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; GROWTH HORMONE; INSULIN; LEPTIN; PROINSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE HOMEOSTASIS; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; GROWTH STIMULATION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHYSICAL DEVELOPMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SMALL FOR DATE INFANT;

EID: 0036134072     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200201000-00014     Document Type: Article

References (51)

1. Metabolic and endocrine findings in appropriate and small for gestational age fetuses
2. Plasma insulin in appropriate- and small-for-gestational-age fetuses
3. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation
4. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth
5. Growth factors and intrauterine growth retardation. I. Serum growth hormone, insulin-like growth factor (IGF)-I, IGF-II, and IGF binding protein 3 levels in normally grown and growth- retarded human fetuses during the second half of gestation
6. Hypersomatotropism in the dysmature infant at term and preterm birth
7. The pathophysiology of the insulin-like growth factor axis in fetal growth failure: A basis for programming by undernutrition?
8. Growth hormone, insulinlike growth factor-I and prolactin in small for gestational age neonates
9. Growth factors and intrauterine growth retardation. II - Serum growth hormone, insulin-like growth factor (IGF)-I, and IGF-binding protein 3 levels in children with intrauterine growth retardation as compared with normal controls: Prospective study from birth to two years of age
10. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn
11. The investigation of growth hormone insensitivity
12. Growth hormone, insulin-like growth factor-I and insulinlike growth factor binding protein-3 are regulated differently in small-for-gestationalage and appropriate-for-gestational-age neonates
13. Long-term growth in small-for-date children
14. Growth in full-term small-for-gestational-age infants: From birth to final height
15. Prediction of the outcome of growth at 2 years of age in neonates with intra-uterine growth retardation
16. Serum insulin-like growth factor I and serum growth-promoting activity during the first postnatal year in infants with intrauterine growth retardation
17. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation
18. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age
19. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children
20. Investigation of growth hormone secretion in patients with intrauterine growth retardation
21. Physiological growth hormone secretion and response to growth hormone treatment in children with short stature and intrauterine growth retardation
22. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth
23. Fetal nutrition and cardiovascular disease in adult life
24. Thinness at birth and insulin resistance in adult life
25. Fetal growth and glucose and insulin metabolism in four-yearold Indian children
26. Insulin resistance in short children with intrauterine growth retardation
27. The effect of growth hormone on glucose metabolism and insulin secretion in man
28. Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man
29. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans
30. Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation
31. Loss of the normal relationships between growth hormone, growth hormonebinding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus
32. Cross sectional stature and weight reference curves for the UK
33. Increased overnight growth hormone concentrations in diabetic compared with normal adolescents
34. Counterregulation during spontaneous nocturnal hypoglycaemia in prepubertal children with type I diabetes
35. Sensitive and specific two-site radioimmunometric assays for human insulin, proinsulin, 65-66 and 32,33 split proinsulin
36. Alterations in the insulin-like growth factor system during the menstrual cycle in normal women
37. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
38. Insulin-like growth factors and their binding proteins
39. Physiological growth hormone secretion in children with short stature and intra-uterine growth retardation
40. Multiple hormone resistance in short children born with intrauterine growth retardation
41. High-dose growth hormone treatment of short children born small for gestafional age
42. Small as a fetus and short as a child: From endogenous to exogenous growth hormone
43. Does growth hormone treatment improve final height attainment of children with intrauterine growth retardation?
44. Metabolic actions of growth hormone: Direct and indirect
45. Effect of human growth hormone treatment on adipose tissue in children
46. Laron syndrome: Typical and atypical forms
47. Spontaneous nocturnal growth hormone secretion in anorexia nervosa
48. Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site
49. Mediation of the hepatic effects of growth hormone by its lipolytic activity
50. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
51. Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-I and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease